Vident Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.76M | Sell |
124,327
-22,865
| -16% | -$1.06M | 0.06% | 243 |
|
|
2025
Q1 | $8.98M | Buy |
147,192
+72,679
| +98% | +$4.43M | 0.13% | 145 |
|
|
2024
Q4 | $4.21M | Sell |
74,513
-3,382
| -4% | -$191K | 0.07% | 238 |
|
|
2024
Q3 | $4.03M | Sell |
77,895
-91,569
| -54% | -$4.74M | 0.1% | 196 |
|
|
2024
Q2 | $7.04M | Sell |
169,464
-605,522
| -78% | -$25.1M | 0.19% | 104 |
|
|
2024
Q1 | $42M | Buy |
774,986
+224,992
| +41% | +$12.2M | 0.88% | 11 |
|
|
2023
Q4 | $28.2M | Buy |
549,994
+55,897
| +11% | +$2.87M | 0.71% | 14 |
|
|
2023
Q3 | $28.7M | Buy |
+494,097
| New | +$28.7M | 0.89% | 12 |
|